PLK1 has been reported to be over-expressed in numerous cancer types, such as non-small-cell lung cancer, oropharyngeal carcinoma, esophageal carcinoma, melanoma, colorectal cancer, hepatoblastoma, non-Hodgkin lymphoma, and others [12]. Here, PLK1 is linked to non-small cell lung carcinoma.